A multidisciplinary team of scientific minds with a deep understanding of IP law, integrating science, technology, and legal strategy to deliver effective IP solutions.
Over 20 years of specialised domain experience, offering strategic insights across multiple therapeutic and technological areas.
Comprehensive IP solutions from concept to market, covering pharma generics, biosimilars, IP M&A, diligence, and contracts
Access to global and regional databases, including CAS SciFinder and national patent repositories, enabling precise IP research and analysis.
Advanced platforms like IPD Analytics and Cortellis Product Intelligence to support data-driven IP strategy and decision-making.
Proprietary curated databases and periodic IP newsletters providing actionable intelligence and industry trends.
We help define robust IP strategies that strengthen innovation pipelines and support market differentiation.
Patent landscape reports Freedom to Operate (FTO), (In)validation and Non-infringement proposals Patent and exclusivity certifications White Space Analysis Technology Evaluation
Comprehensive management of IP assets from creation to commercialisation, ensuring alignment with business goals.
Patentability analysisDrafting, filing, and prosecution of Patent, Design & Trademark applications Para IV with First-to-File (FTF) / First-to-Market opportunities 505(b)(2) / Differentiated Product Development Opportunities
Safeguarding innovation through robust legal actions and proactive protection strategies.
Patent & Trademark opposition, invalidity, and revocation proceedingsEnforcement of patent rights through infringement litigationDue diligence on potential infringersAdvisory on Orange Book (OB) listings
Transforming IP assets into business value through effective monetisation and partnership strategies.
Patent & Trademark due diligence in M&A IP Licensing & AssignmentAt-Risk Launch GuidanceCompetitor IntelligenceDrafting of commercial agreements
Comprehensive support through the entire litigation process, ensuring informed and strategic legal actions.
Advisory on Hatch-Waxman Law and BPCI (Act for Biosimilars) Document & e-discovery, deposition supportLitigation Support IP Settlement and Negotiation
Copyright © 2026 Pivot Path Private Limited. All rights reserved.